AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verhoef, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Verhoef, H.
Agricola
Right arrow Articles by Verhoef, H.
American Journal of Clinical Nutrition, Vol. 82, No. 5, 1137-1138, November 2005
© 2005 American Society for Clinical Nutrition


LETTER TO THE EDITOR

Reply to SA Tanumihardjo and BA Underwood

Hans Verhoef

Cell Biology and Immunology Group
PO Box 338
Wageningen University
Wageningen 6700 AH
Netherlands

E-mail: hans.verhoef{at}wur.nl

Dear Sir:

Because of their role in the development of the relative-dose-response (RDR) and modified-relative-dose-response (MRDR) tests, Tanumihardjo and Underwood (1) are particularly well-placed to comment on the assumptions made in our article (2). They are incorrect, however, that we claimed that the results of the dose-response tests were due to random variation. Because the formulas used to compute the RDR and MRDR incorporate the serum retinol concentration, which is related to liver stores of retinol in individuals with vitamin A deficiency (3), we concluded that these tests may in fact be correlated with marginal or depleted liver stores. Our models served to illustrate, however, that any interpretation of the relation between dose-response values and serum retinol is necessarily compromised because of the occurrence of a mathematical artifact. Random variation in the serum retinol concentration contributes to this artifact.

The magnitude, but not the extant, of this artifact depends on the values of the variables used to calculate the dose response, eg, serum retinol concentrations at baseline (R0) and 5 h after dosing (R5) with the RDR. In our models, these values were generated arbitrarily to be within ranges reported by Wieringa et al (4) and Tanumihardjo et al (5). Tanumihardjo and Underwood take issue with the frequency of RDR values <0 and >0.4 in our models. However, negative values have been reported repeatedly, which is incompatible with the concept of the RDR, because this was originally conceived as "the degree by which plasma vitamin A levels otherwise ‘normal’ to an individual are reduced by deficiencies in hepatic stores" (6) [sic]. More pertinent, the negative relation illustrated in our Figures 1 and 2 shows that the mathematical artifact exists across the range of RDR values that Tanumihardjo and Underwood appear to consider realistic, ie, 0.0-0.4.

Our reasons for assuming R0 and R5 to be independent in our models 1 and 2 are outlined in our article (1) and in a letter by Verhoef (7) in this issue of the Journal. The claim by Tanumihardjo and Underwood that R5 values approximate the homeostatically regulated serum retinol concentration only in vitamin A-replete individuals, and not when liver stores are inadequate, is not substantiated by the report to which they refer (8), and contradicts the report by Lörch et al (6) and evidence put forward in my letter (7). However, if Tanumihardjo and Underwood are correct, then a model similar to ours could be used to examine the extent to which incorporation of this relation between the R0 and R5 would reduce the magnitude of the artifact.

Tanumihardjo and Underwood claim that several studies have shown that an improvement in the MRDR can co-exist with unchanged serum retinol concentrations. As we pointed out (1), however, a small change in serum retinol concentration, particularly in the low range toward zero, will necessarily result in a relatively large change in the MRDR because the serum retinol concentration constitutes the denominator in the formula to compute the MRDR. This can misleadingly provide the impression in population studies that the MRDR is more responsive to changes in the vitamin A status than in the serum retinol concentration; this greater responsiveness will necessarily be accompanied by a greater variance. Substitution of serum retinol concentration by its reciprocal, as is done when the MRDR is calculated, does not provide additional information about vitamin A status.

Tanumihardjo and Underwood state that false-positive results (ie, individuals incorrectly classified as being vitamin A deficient) are rare when the MRDR is used in vitamin A-sufficient individuals. However, the cutoffs for MRDR used in various studies to indicate vitamin A deficiency were defined on the basis of normal values in populations believed to be vitamin A sufficient (1, 7) and not on published evidence about the relation between hepatic retinol stores (or a proxy indicator thereof) in humans and the MRDR. Thus, this claim appears to be the result of a circular argument.

Tanumihardjo and Underwood are also incorrect that we suggested that the 3,4-didehydroretinol response was due to random variation. Because we wanted to show the effect of group differences in serum retinol concentration only, we assumed in our model 3 that the distribution of 3,4-didehydroretinol was random and identical in both groups. As with the models used for the RDR, models similar to ours could be used to incorporate a possible relation between serum concentrations of retinol and 3,4-didehydroretinol and to further explore the magnitude of the mathematical artifact that we described for the MRDR.

ACKNOWLEDGMENTS

The author had no conflict of interest to disclose.

REFERENCES

  1. Verhoef H, West CE. Validity of the relative-dose-response test and the modified-relative-dose-response test as indicators of vitamin A stores in liver. Am J Clin Nutr 2005;81:835-9.[Abstract/Free Full Text]
  2. Tanumihardjo SA, Underwood BA. Utility of the relative-dose-response and modified-relative-dose-response tests as population indicators of vitamin A status. Am J Clin Nutr 2005;82:1135(letter).
  3. Olson JA. Serum levels of vitamin A and carotenoids as reflectors of nutritional status. J Natl Cancer Inst 1984;73:1439-44.
  4. Wieringa FT, Dijkhuizen MA, West CE, Thurnham DI, Muhilal, Van der Meer JWM. Redistribution of vitamin A after iron supplementation in Indonesian infants. Am J Clin Nutr 2003;77:651-7.[Abstract/Free Full Text]
  5. Tanumihardjo SA, Muhilal, Yuniar Y, et al. Vitamin A status in preschool-age Indonesian children as assessed by the modified-relative-dose response assay. Am J Clin Nutr 1990;52:1068-72.[Abstract/Free Full Text]
  6. Lörch JD, Underwood BA, Lewis KC. Response to plasma levels of vitamin A to a dose of vitamin A as an indicator of hepatic vitamin A reserves in rats. J Nutr 1979;109:778-86.
  7. Verhoef H. Reply to FT Wieringa and RS Hasan Sadikin. Am J Clin Nutr 2005;82:1139(letter).[Free Full Text]
  8. Underwood BA. Biochemical and histological methodologies for assessing vitamin A status in human populations. Methods Enzymol 1990;190:242-51.[Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verhoef, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Verhoef, H.
Agricola
Right arrow Articles by Verhoef, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS